featured
Measurable Residual Disease at Induction Redefines Partial Response in AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations
J. Clin. Oncol 2018 Mar 30;[EPub Ahead of Print], SD Freeman, RK Hills, P Virgo, N Khan, S Couzens, R Dillon, A Gilkes, L Upton, OJ Nielsen, JD Cavenagh, G Jones, A Khwaja, P Cahalin, I Thomas, D Grimwade, AK Burnett, NH RussellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.